STEVE PAKOLA

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEVE PAKOLA:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Medical Officer Common Stock 258,317 $3,719,790 $14.40 06 Jan 2026 Direct
REGENXBIO Inc. Chief Medical Officer Stock Options (Right to buy) 35,402 06 Jan 2026 Direct

Insider Reports Filed by STEVE PAKOLA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 06 Jan 2026 2 $0 4 Chief Medical Officer 08 Jan 2026, 16:44
RGNX REGENXBIO Inc. 02 Jan 2026 1 -$262,757 4 Chief Medical Officer 06 Jan 2026, 16:31
RGNX REGENXBIO Inc. 01 Feb 2025 1 -$42,472 4 Chief Medical Officer 04 Apr 2025, 17:17
RGNX REGENXBIO Inc. 02 Jan 2025 3 -$107,377 4 Chief Medical Officer 06 Jan 2025, 16:59
RGNX REGENXBIO Inc. 01 Aug 2024 1 $0 4 Chief Medical Officer 05 Aug 2024, 18:41
RGNX REGENXBIO Inc. 05 Mar 2024 3 -$78,685 4 Chief Medical Officer 07 Mar 2024, 18:05
RGNX REGENXBIO Inc. 02 Jan 2024 4 -$486,200 4 Chief Medical Officer 04 Jan 2024, 16:23
RGNX REGENXBIO Inc. 03 Jan 2023 4 -$111,223 4 Chief Medical Officer 05 Jan 2023, 15:06
RGNX REGENXBIO Inc. 01 Jan 2022 4 -$91,603 4 Chief Medical Officer 04 Jan 2022, 20:05